Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
08/02/2012 | US20120198577 Method of Isolating Human Neuroepithelial Precursor Cells from Human Fetal Tissue |
08/02/2012 | US20120198576 Methods for making embryonic cells, embryos, and animals sensitized to stress |
08/02/2012 | US20120198575 Methods and compositions for determining the purity of chemically synthesized nucleic acids |
08/02/2012 | US20120197189 Method for producing autonomously contracting cardiac muscle cells from adult stem cells, in particular human adult stem cells |
08/02/2012 | US20120197068 Sperm Diluent Solution and Method for Artificial Insemination Using Same |
08/02/2012 | US20120196924 METHODS AND PRODUCTS FOR EXPRESSION OF MICRO RNAs |
08/02/2012 | US20120196923 Polymers for delivering a substance into a cell |
08/02/2012 | US20120196869 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels |
08/02/2012 | US20120196849 Compounds and compositions as hedgehog pathway modulators |
08/02/2012 | US20120196844 Compounds and compositions as modulators of gpr119 activity |
08/02/2012 | US20120196838 Compounds for inflammation and immune-related uses |
08/02/2012 | US20120196826 Methods for transdifferentiation of body tissues |
08/02/2012 | US20120196815 Withanolide Isolated from Physalis longifolia and Analogs and Methods of Use Thereof |
08/02/2012 | US20120196769 Methods of repairing tandemly repeated DNA sequences and extending cell life-span using nuclear transfer |
08/02/2012 | US20120196760 Methods and compositions for identifying modulators of anti-tetherin activity to inhibit propagation of viruses |
08/02/2012 | US20120196749 Cyclosporin Derivatives |
08/02/2012 | US20120196369 Method for forming culture medium |
08/02/2012 | US20120196368 Culture medium |
08/02/2012 | US20120196367 Method for culturing cells on culture medium |
08/02/2012 | US20120196366 Method for forming nerve graft |
08/02/2012 | US20120196365 Differentiation of Pluripotent Stem Cells |
08/02/2012 | US20120196364 Inhibition of migration and induction of cell death by the type ii collagen amino propeptides |
08/02/2012 | US20120196363 Method for modulating activity of t lymphocytes |
08/02/2012 | US20120196362 Method for treatment and storage of platelets |
08/02/2012 | US20120196361 Mart-1 t cell receptors |
08/02/2012 | US20120196360 Method of efficiently establishing induced pluripotent stem cells |
08/02/2012 | US20120196359 POLY-N-ACETYL GLUCOSAMINE (PNAG/dPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF |
08/02/2012 | US20120196358 Device for removing cumulus from oocytes |
08/02/2012 | US20120196328 Fusion protein mixture for inducing human pluripotent stem cell and preparation method there of |
08/02/2012 | US20120196327 Process for production of protein |
08/02/2012 | US20120196321 Selectable markers and related methods |
08/02/2012 | US20120196312 Culture medium for epithelial stem cells and organoids comprising the stem cells |
08/02/2012 | US20120196308 Methods and Kits for Measuring Von Willebrand Factor |
08/02/2012 | US20120196282 Method of regenerating elastic fiber and screening method |
08/02/2012 | US20120196281 Functionalized organotypic systems |
08/02/2012 | US20120196275 Multicellular organotypic model of human intestinal mucosa |
08/02/2012 | US20120195943 Bone delivery device |
08/02/2012 | US20120195942 Dosage forms of active ingredients containing hydroxystilbene for treating menopausal complaints |
08/02/2012 | US20120195939 Parenteral composition comprising microspheres with a diameter between 10 and 20 microns |
08/02/2012 | US20120195928 Vaccines and methods for using the same |
08/02/2012 | US20120195927 Gm-negative ehv-mutants without heterologous elements |
08/02/2012 | US20120195917 Vaccine Composition Comprising 5'-CAP Modified RNA |
08/02/2012 | US20120195915 IAP BIR domain binding compounds |
08/02/2012 | US20120195912 Cripto Blocking Antibodies and Uses Thereof |
08/02/2012 | US20120195910 Anti-pcsk9 antibodies and methods of use |
08/02/2012 | US20120195909 Antibodies against a proliferating inducing ligand (april) |
08/02/2012 | US20120195903 Method for the production of antibodies |
08/02/2012 | US20120195901 Compositions and Methods for Binding Lysophosphatidic Acid |
08/02/2012 | US20120195900 Tri-variable domain binding proteins and uses thereof |
08/02/2012 | US20120195897 Human domain antibodies against components of the human insulin-like growth factor (igf) system |
08/02/2012 | US20120195879 Carrier immunoglobulins and uses thereof |
08/02/2012 | US20120195874 Dfpase enzymes from aplysia californica |
08/02/2012 | US20120195866 PKD Ligands and Polynucleotides Encoding PKD Ligands |
08/02/2012 | US20120195864 Cells genetically modified to comprise pancreatic islet glucokinase and uses thereof |
08/02/2012 | US20120195863 Methods and apparatus for enhanced recovery of cells and of cell-enriched matrix from tissue samples |
08/02/2012 | US20120195862 Biomechanical induction of hematopoiesis |
08/02/2012 | US20120195861 Methods and compositions for producing germ cells from peripheral blood derived germline stem cells |
08/02/2012 | US20120195860 Latent neural stem cell population |
08/02/2012 | US20120195854 Granulysin in immunotherapy |
08/02/2012 | US20120195850 Use of polymer d-lactic acid (pdla) or equivalents thereof to inhibit growth of cancer cells and diagnose cancers |
08/02/2012 | US20120195834 Method of testing a drug for anti-cancer activity |
08/02/2012 | US20120195830 Monoclonal Antibodies Against Claudin-18 For Treatment of Cancer |
08/02/2012 | CA2827179A1 Zscan4 as a marker for pancreatic stem cells and progenitor cells and use thereof |
08/02/2012 | CA2825924A1 Respiratory metabolism-associated gene bnaox1 from brassica napus and use thereof |
08/02/2012 | CA2825722A1 Expression of soluble viral fusion glycoproteins in mammalian cells |
08/02/2012 | CA2825573A1 Humanized anit-egfr antibody l4-h3 and coding gene thereof |
08/02/2012 | CA2825553A1 Neural cell purification for transplantation |
08/02/2012 | CA2823719A1 Methods for generating inner ear cells in vitro |
08/01/2012 | EP2481814A2 Compositions and methods for treating and diagnosing cancer |
08/01/2012 | EP2481808A1 Amelioration of metabolic syndrome or method for screening for ameliorating agent for metabolic syndrome utilizing physiological function of sphingomyelin synthase sms2 |
08/01/2012 | EP2481795A1 Method of generating induced pluripotent stem cells and differentiated cells |
08/01/2012 | EP2481794A1 Patterned substrates for cell applications |
08/01/2012 | EP2481748A2 Foxp3 peptide vaccine |
08/01/2012 | EP2481422A2 Multiplex vaccines |
08/01/2012 | EP2481287A1 Human skin equivalents expressing exogenous polypeptides |
08/01/2012 | EP2480665A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
08/01/2012 | EP2480658A1 Method of preparing plant-derived vlps |
08/01/2012 | EP2480657A1 Method of efficiently establishing induced pluripotent stem cells |
08/01/2012 | EP2480656A2 Medium for handling and storing biological tissues of the musculoskeletal system outside an organism |
08/01/2012 | EP2480655A2 Cell culture medium |
08/01/2012 | EP2480560A1 Method of preparing plant-derived proteins |
08/01/2012 | EP2149382B1 Dentinogenesis inducer and dentinogenesis pulp-capping material |
08/01/2012 | EP1976975B1 In vitro expansion of postpartum derived cells in roller bottles |
08/01/2012 | EP1855524B1 Transgenic animal as a model for fibrotic diseases |
08/01/2012 | EP1728864B1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy |
08/01/2012 | EP1685159B1 Tim-3 polypeptides |
08/01/2012 | EP1572862B1 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
08/01/2012 | EP1531865B1 Hepatocyte growth factor (HGF) and/or insulin-like growth factor-1 (IGF-1) for use in myocardial regeneration |
08/01/2012 | EP1402076B1 Methods for evaluating patient treatment by inhibitors of virus entry using recombinant virus assays |
08/01/2012 | EP1346049B1 Efficient expression of plasmodium apical membrane antigen 1 in yeast cells |
08/01/2012 | EP1333853B1 Growth factor complex |
08/01/2012 | EP1133310B1 Artery- and vein-specific proteins and uses therefor |
08/01/2012 | EP0574402B2 Expression of pace in host cells and methods of use thereof |
08/01/2012 | CN102625848A Simultaneous, integrated selection and evolution of antibody/protein performance and expression in production hosts |
08/01/2012 | CN102625837A Method of efficiently establishing induced pluripotent stem cells |
08/01/2012 | CN102625832A Generation of CTL lines with specificity against multiple tumor antigens or multiple viruses |
08/01/2012 | CN102625831A Methods and compositions for improving the viability of cryopreserved cells |
08/01/2012 | CN102625830A 间充质干细胞分化 Mesenchymal stem cell differentiation |
08/01/2012 | CN102625813A Immunoglobulins with reduced aggregation |
08/01/2012 | CN102621322A Kit for detecting 3-methyl-quinoxaline-2-carboxylic acid |